Roche (RHHBY) announced that the Food and Drug Administration has approved a New Drug Application for an Evrysdi tablet for people living with ...
Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult ...
Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...
New 5mg tablet offers the same established efficacy and safety as the Evrysdi oral solution for individuals living with spinal muscular atrophy.
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an Evrysdi ® ...
'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...
For those worried about breaking their backs carrying their laptops to every business trip they embark on, a tablet may be their best option. Tablets are just as powerful as regular laptops in ...
The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...
It entered the Android and Windows tablet market in 2011, began selling Android smartphones in 2012, and acquired Motorola Mobility from Google in 2014. The company has also launched an online-only ...
It’s a hard pill — or 50 — to swallow. Bahram Akradi ... FilmMagic “At 63, I’m competing with 33-year-olds,” he told Business Insider. “They say, ‘Tell me what you’re taking ...
Amazon’s Fire tablets are some of the cheapest slates you can buy, and the Amazon Fire 7 is the least expensive yet.It’s not the best performer, but for the $60 asking price (or $75 if you ...
It released its first Android smartphone in 2009, and can be credited with the launch of the first Android tablet back in 2010. The company is among the biggest players in the smartphone market in the ...